We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
Figure 2

Figure 2. From: Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism.

Changes in uric acid metabolism at baseline (before) and after the addition of losartan. (A, B, C) 1, baseline; 2, benzbromarone; 3, benzbromarone + losartan. (D, E, F) 1, baseline; 2, allopurinol; 3, allopurinol + losartan.

S Takahashi, et al. Ann Rheum Dis. 2003 June;62(6):572-575.
2.
Figure 1

Figure 1. From: Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism.

Changes in uric acid metabolism at baseline (before) and after the addition of fenofibrate. (A, B, C) 1, baseline; 2, benzbromarone; 3, benzbromarone + fenofibrate. (D, E, F) 1, baseline; 2, allopurinol; 3, allopurinol + fenofibrate.

S Takahashi, et al. Ann Rheum Dis. 2003 June;62(6):572-575.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk